2013, Number 1
<< Back
Rev Mex Patol Clin Med Lab 2013; 60 (1)
Leptospirosis; a public health problem
García-González R, Reyes-Torres A, Basilio-Hernández D, Ramírez-Pérez M, Rivas-Sánchez B
Language: Spanish
References: 40
Page: 57-70
PDF size: 188.61 Kb.
ABSTRACT
Leptospirosis is a zoonotic disease with a worldwide distribution, and occurs in tropical, subtropical and temperate zones. Considered to be the most geographically widespred zoonosis. Leptospirosis has been recognized as an emerging global public health problem because of its increasing incidence in both developing a developed countries. More than 500,000 cases of severe leptospirosis are reported each year, with fatality rates exceeding 10%. The genus
Leptospira comprises saprophytic and pathogenic species, isolated from wide range of animal reservoir species. Laboratory diagnosis is complex and not widely available, Selection of the right specimens, tests and correct interpretation of test results are important parameters to provide better patient care. The
Leptospira is detected by isolation of organism or demonstration by dark field, silver impregnation and immunodetection; microagglutination and immunofluorescence or amplification of specific fragment of Leptospiral DNA and indirect evidences by detection of antibodies to leptospires.
REFERENCES
Levett PN. Leptospirosis. Clin Microbiol Rev 2001; 14: 296-326.
Dolhnikoff M, Mauad T, Bethlem EP, Ribeiro CR. Pathology and pathophysiology of pulmonary manifestations in leptospirosis. Bras J Infect Dis 2007; 11: 142-148.
Erosa-Barbachano G. Leptospirosis. Rev Biomed 2001; 12: 282-287.
Terpstra WJ. Historical perspectives in leptospirosis. Indian J Med Microbiol 2006; 24: 316-320.
Wood WB. Enfermedad de Weil. En: Cecil, Rusell, (eds). Tratado de Medicina Interna. México: Interamericana, 1947: 578-583.
Noguchi H, Kligler J. Experimental studies on yellow fever occurring in Merida. Yucatán. J Exp Med 1920; 32: 601-625.
Noguchi H, Kligler J. Immunological studies with a strain of Leptospira isolated from a case of yellow fever in Merida, Yucatán. J Exp Med 1920; 32: 627-637.
Varela G, Zavala VJ. Estudio serológico de la leptospirosis en la República Mexicana. Rev Inst Salubr Enf Trop 1961; 21: 49-52.
De Igartua LE, Coutiño RMR, Velásco CO. Revisión breve de leptospirosis en México. Altepepaktli Salud para la Comunidad 2005; 1: 52-58.
Caballero SA, Romero GJ. Leptospirosis en México. Premio Canifarma. Ind Farmaceut Vet 1991; 1: 107-124.
Gavaldón DG, Cisneros MA, Rojas N, Moles-Cervantes LP. La importancia de la leptospirosis humana en México. Detección de anticuerpos antileptospira en una población de donadores de sangre. Gac Med Mex 1995; 131: 289-292.
Navarrete-Espinosa J, Acevedo-Vales J, Huerta-Hernández E, Torres-Barranca J, Gavaldón-Rosas DG. Prevalencia de anticuerpos contra dengue y Leptospira en la población de Jáltipan, Veracruz. Sal Pub Mex 2006; 48: 220-228.
Navarrete-Espinosa J, Moreno-Muñoz,M, Rivas-Sánchez B, Velásco-Castrejón O. Leptospirosis prevalence in a population of Yucatan, Mexico. J Pathogens 2011. Article ID: 408604, 5p, Doi: 10,4061/2011/408604.
Dong H, Hu Y, Xue F, Sun D, Oicius DM, Mao Y et al. Characterization of the ompL1 gene of pathogenic Leptospira species in China and cross-immunogenicity of the OmpL1 protein. BMC Microbiol 2008; 8: 223-234.
Ko AI, Goarant C, Picardeau. Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen. Nat Rev Microbiol 2009; 7: 736-747.
Trueba G, Zapata S, Madrid K, Cukken O, Haake D. Cell aggregation a mechanism of pathogenic Leptospira to survive in fresh water. Int Microbiol 2004; 7: 35-40.
Rodríguez I, Rodríguez JE, Fernández C. Alcalinización de la orina humana para el aislamiento experimental de Leptospiras. Rev Cubana Med Trop 2005; 57: 55-56.
Abuauada MC, Osorio SG, Rojas PML, Lorena-Pino V. Leptospirosis: Presentación de una infección fulminante y revisión de la literatura. Rev Chil Infect 2005; 22: 93-97.
Organización Panamericana de la Salud, Organización Mundial de la Salud e International Leptospirosis Society. Leptospirosis humana: Guía para el diagnóstico, vigilancia y control. Serie de Manuales Técnicos, 12. VP/OPS/OMS, 2008. Disponible en: www2paho.org/hq/dndocuments/WHO-Guia-Lepto-2003-spa.pdf
Céspedes ZM. Leptospirosis: Enfermedad zoonótica reemergente. Rev Peru Med Exp Salud Pública 2005; 22: 290-307.
Brihuega B. Leptospirosis: Diagnóstico y tipificación de Leptospiras. En: Cacchione R, Durlach R, Martino P (eds). Tema de Zoonosis IV. Buenos Aires, Arg: Asociación Argentina de Zoonosis, 2008: 224-227.
Hartskeer IRA. International Leptospirosis Society. Objectives and achievements. Rev Cub Med Trop 2005; 57: 7-10.
Vijayachari P, Sugunan Ap, Shriram AM. Leptsopirosis: an emerging global public health problem. J Biosci 2008; 33: 557-569.
World Health organization. 1999. Leptospirosis worldwide, 1999. Wkly Epidemiol Rec 1999; 74: 237-242.
Hartskeer IRA, Collares-Pereira M, Ellis WA. Emergence, control and re-emerging leptospirosis; dynamics of infection in the changing world. Clin Microbiol Infect 2001; 494-501.
Sistema Único de Información para la Vigilancia Epidemiológica/Dirección General de Epidemiología/SSA. Boletín epidemiológico.
Nascimento LTO, Ko AI, Martins AEL, Monteiro-Vitorello CB, Ho PL, Haake DA et al. Comparative genomics of two Leptospira interrogans serovars reveal novel insights into physiology and pathogenesis. J Bacteriol 2004; 186: 2164-2172.
Lin Y-P, McDonough SP, Sharma Y, Chang Y-E. The terminal immunoglobulin-like repeats of LigA and LigB of Leptospira enhance their binding to gelatin binding domain of fibronectin and host cells. Plus One 2010; 5(6):e11301.
Matsunaga J, Barocchi MA, Croda J, Young TY, Sánchez Y, Siqueira I et al. Pathogenic Leptospira species express surface-exposed proteins belonging to the bacterial immunoglobulin superfamily. Mol Microbiol 2003; 49: 929-945.
Cinco M. New insights into the pathogenicity of leptospires: evasion of ther host defences. New Microbiologic. 2010; 33: 283-292.
Nally JE, Choe E, Fishbein MC, Blanco DR, Lovett MA. Changes in lipopolysaccharide O antigen distinguish acute versus chronic Leptospira interrogans infections. Infect Immun 2005; 73: 3251-3260.
Barocchi MA, Ko AI, Reis MG, McDonald KI, Tiley LW. Rapid translocation of polarized MDCK cell monolayers by Leptospira interrogans, an invasive but nonintreacellular pathogen. Infect Immun 2002; 70: 6926-6932.
Faine S. Leptospira and leptospirosis. Boca Ratón, Florida: CRC Press, 1994: 353.
Velasco-Castrejón O. Seguimiento de pacientes con leptospirosis crónica. Mem Symp Importancia de la Leptospirosis como una zoonosis reemergente en México. México ISB: Coordinación de Vigilancia Epidemiológica, SSa, 1998: 9-12.
Avdeeva MG. Outcome and tendency of late convalescence in icterohaemorrhagic leptopsirosis. Klin Med (Mosk) 2003; 81: 42-47.
Rathinam SR. Ocular manifestations of leptospirosis. J Postgrad Med 2005; 51: 189-194.
Elizalde 2004 Elizalde CAA, Tenorio GG, Velasco-Castrejón O. Identificación de Leptospira en la patogénesis de la uveítis crónica en la Ciudad de México. Rev Mex Oftalmol 2004; 78: 165-170.
Nicolesco M, Andrescu N. May human leptospirosis develops as a chronic infection? Zentralbl Bakteriol Mikrobiol Htg 1984; 257: 531-534.
Velasco-Castrejón O, Rivas-Sánchez B, Rivera-Reyes HH. Transición de la leptospirosis aguda a crónica. Seguimiento de siete casos. Rev Mex Patol Clin 2009; 56: 183-192.
OIE. Leptospirosis (Chapter 2.2.4). In: Manual of diagnostic test and vaccines for terrestrial animals. 5th ed., 2004. Available in: www.oie.int/en/international-standar-setting/terrestrial-manual/access-online/